 |
|
|
|
|
|
|
|
|
|
|
|
1 to 30 of 141 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Koo E. on LIVE DISCUSSION: Messing with the Membrane—An Alternative Interpretation of the Amyloid-β Hypothesis, As is often the case, an outsider can give fresh perspectives in ways that someone from the... 20 Sep 2005.
|
|
|
 |
|
|
Koo E. on PAPER: Marchesi VT. et al., 2005, As is often the case, an outsider can give fresh perspectives in ways that someone from the... 20 Sep 2005.
|
|
|
|
|
|
Golde T, Koo E. on NEWS: Naproxen/Rofecoxib Trial Results Published, The study by Aisen et al. shows no benefit to rofecoxib or naproxen in patients with mild to... 9 Jun 2003.
|
|
|
|
|
|
Koo E. on PAPER: Inomata H. et al., 2003, In a detailed and carefully performed study, Inomata and colleagues provide some intriguing new... 11 Apr 2003.
|
|
|
|
|
|
Koo E. on NEWS: Aβ's Shadowy Sibling—What Becomes of the Intracellular Domain?, In a detailed and carefully performed study, Inomata and colleagues provide some intriguing new... 11 Apr 2003.
|
|
|
|
|
|
Koo E. on NEWS: Aβ's Shadowy Sibling—What Becomes of the Intracellular Domain?, In this paper, Scheinfeld and colleagues from the D’Adamio laboratory extended their work on the... 5 Feb 2003.
|
|
|
|
|
|
Koo E. on PAPER: Sparks DL. et al., 2002, Recommendation Only. 30 Jan 2003.
|
|
|
|
|
|
Koo E. on PAPER: Ehehalt R. et al., 2003, Recommendation Only. 30 Jan 2003.
|
|
|
|
|
|
Koo E. on PAPER: Luo WJ. et al., 2003, One of several studies that show that APH-1 and PEN-2 function together in the gamma-secretase... 30 Jan 2003.
|
|
|
|
|
|
Koo E. on PAPER: Dou F. et al., 2003, Recommendation Only. 30 Jan 2003.
|
|
|
|
|
|
Koo E. on PAPER: Gianni D. et al., 2003, Recommendation Only. 30 Jan 2003.
|
|
|
|
|
|
Koo E. on PAPER: Kimberly WT. et al., 2003, Interesting study that optimizes an in vitro gamma-secretase cleavage assay. While the results... 30 Jan 2003.
|
|
|
|
|
|
Koo E. on PAPER: Deininger MH. et al., 2002, Recommendation Only. 31 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Ryu EJ. et al., 2002, Recommendation Only. 31 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Lee EB. et al., 2003, Recommendation Only. 31 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Sparks DL. et al., 2002, Interesting speculation but the proof will be in the pudding. Ultimately, we don't yet know what... 31 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Moriguchi A. et al., 2002, Interesting observations. It will be even more interesting to see what happens in APP... 31 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Onuki R. et al., 2002, Recommendation Only. 7 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Asante EA. et al., 2002, Recommendation Only. 7 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Kienzl E. et al., 2002, I look forward to replication of this finding. 7 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Almkvist O. et al., 2002, This comparison reinforces the idea that MCI is really a hetergenous group of individuals. 7 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Tschäpe JA. et al., 2002, No obvious direct link between AMPK and APPL (or APP). But it may be indirect, through membrane... 7 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Ni CY. et al., 2003, Recommendation Only. 7 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Laurin D. et al., 2002, Hard to know whether the negative association is a true negative. One might have thought there... 7 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Azzouz M. et al., 2002, Recommendation Only. 7 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Xiang Z. et al., 2002, Somewhat surprising results, perhaps. But show how complicated the COX/abeta relationship in... 7 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Spooner ET. et al., 2002, Recommendation Only. 7 Dec 2002.
|
|
|
|
|
|
Koo E. on PAPER: Hartman RE. et al., 2002, Another thorough analysis of the PDAPP mice from the Holtzman lab. If one believes the human... 7 Dec 2002.
|
|
|
|
|
|
|
|
|
|
1 to 30 of 141 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
